You have been chosen to receive this valuable information.
 
A SPECIAL
ANNOUNCEMENT FROM:
  ACT Logo  
 
 
Open the door. Jump in the driver's seat. Get a head start on your professional year. Add noreply@DIAglobal.org.
 
 
DIA Europe 2019
The flagship conference brings together more leaders to discuss more challenges and to provide you with more solutions. Everyone and everything is at DIA Europe 2019.
 
WHY YOU SHOULD ATTEND DIA EUROPE 2019
 
REGISTER TODAY
 
DOWNLOAD OUR 4 STEP GUIDE FOR APPROVAL
 
2019 Speaker Showcase:
 
 
  Lf Border   Guido Rasi, MD, Executive Director, EMA, joins the ever-popular European Regulatory Town Hall alongside fellow Chairs and Directors leading the future of medicines development and access throughout Europe.  
 
 
  Lf Border   Anthony Humphreys, MPharm, Head of Scientific Committees Regulatory Science Strategy, EMA, will share the first European public update, after the EMA multi-stakeholder meeting, on the Agency's draft Regulatory Science Strategy 2020-2025.  
 
 
  Lf Border   Fergus Sweeney, PhD, Head of Inspections and Human Medicines Pharmacovigilance (Division), EMA, joins the essential ICH Info Day.  
 
 
  Lf Border   Sabine Straus, MD, PhD, MSc, PRAC Chair, Staff Member, Medicines Evaluation Board (MEB) chairs the critical discussion Impact of Pharmacovigilance on Public Health.  
 
 
  Lf Border   Sandra Kweder, MD, Deputy Director, Liaison to the EMA, Office of International Programs, OC, FDA brings her expertise to two sessions on Optimising Orphan and Paediatric Drug Development.  
 
 
  Lf Border   Pierre Meulien, PhD, Executive Director, Innovative Medicines Initiative (IMI), gives insights into the public-private partnership between the European Union and the European pharmaceutical industry during Patient Engagement as a Strategic Imperative in Therapeutic Innovation.  
 
WHO WILL INSPIRE YOU?
 
Topics Designed to Advance Healthcare Outcomes
 
 
  Lf Border   How Can Different Stakeholders Support Regulatory System Optimisation?  
 
 
  Lf Border   Evolution of Science and Policy – Where Are We Heading?  
 
 
  Lf Border   Towards 2020 and Beyond in Pharmacovigilance  
 
 
  Lf Border   Modern Clinical Research and Paradigm Shift  
 
 
  Lf Border   Transforming Medical Affairs and Communications  
 
 
  Lf Border   Combatting Fragmentation in Access to Medicines – Shaping the System  
 
 
  Lf Border   Digital Disruptors Changing the Game  
 
 
  Lf Border   Regional Updates  
 
DOWNLOAD PROGRAMME PREVIEW
 
We hope you will join us in Vienna on 5-7 February! spacer
 
 
facebook   linkedin   Twitter   instagram   youtube

Email Preferences
  |   Sign In
 
DIA | Kuechengasse 16 | 4051 Basel, Switzerland
T. +41.61.225.51.51 | E. Basel@DIAglobal.org
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Applied Clinical Trials, a UBM publication. You are on the mailing list as %%emailaddress%%.